ArticleDiabetes, obesity & metabolism2026

An open-label study on ulotaront's effects on insulin-glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I.

Snezana Milanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.